Byron Robinson - Mar 1, 2022 Form 3 Insider Report for Janux Therapeutics, Inc. (JANX)

Signature
Maria Dobek, Attorney-in-Fact
Stock symbol
JANX
Transactions as of
Mar 1, 2022
Transactions value $
$0
Form type
3
Date filed
3/3/2022, 04:03 PM
Next filing
Jan 5, 2023

No securities are beneficially owned.